Tag: Osimertinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Osimertinib

AstraZeneca Tagrisso gets approval in Japan for early-stage lung cancer subtype

Added to Collection on: 2022-08-25 08:41:56

Tags for this article:

Lung cancer
Organic compounds
Chemical compounds
Cancer
T790M
Osimertinib
Non-small-cell lung carcinoma
Epidermal growth factor receptor
AstraZeneca
Targeted therapy of lung cancer

Click the tags to see associated articles and topics

View Article Details
EQRx: Saving American Lives, Made Possible By Low Cost Chinese Drugs - Seeking Alpha

Added to Collection on: 2022-08-28 11:07:34

Tags for this article:

Chemical compounds
Organic compounds
Lung cancer
Cancer
Quinazolines
Amines
Ethers
Tyrosine kinase receptors
Gefitinib
Osimertinib
Durvalumab
Non-small-cell lung carcinoma
Getty Images
China
United States

Click the tags to see associated articles and topics

View Article Details
Tagrisso demonstrated 5.5-year median disease-free survival in adjuvant treatment of ...

Added to Collection on: 2022-09-11 06:34:34

Tags for this article:

Lung cancer
Cancer
Neoplasms
Clinical medicine
Non-small-cell lung carcinoma
Small-cell carcinoma
Osimertinib
Adjuvant therapy
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca plc 18.0% potential upside indicated by Deutsche - DirectorsTalk Interviews

Added to Collection on: 2022-10-04 20:26:34

Tags for this article:

Organic compounds
Chemical compounds
AstraZeneca
Companies
Bristol-Myers Squibb
Södertälje Municipality
Monoclonal antibodies
Durvalumab
Dapagliflozin
Saxagliptin
Osimertinib
Zeneca
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
AstraZeneca (NYSE:AZN) Upgraded to Strong-Buy at StockNews.com - ETF Daily News

Added to Collection on: 2022-11-15 08:59:56

Tags for this article:

Companies
Chemical compounds
Organic compounds
AstraZeneca
Södertälje Municipality
AZN
Bristol-Myers Squibb
Ethers
Zeneca
Dapagliflozin
Durvalumab
Osimertinib

Click the tags to see associated articles and topics

View Article Details
Drugmakers to raise prices on at least 350 drugs in U.S. in January | National Post

Added to Collection on: 2022-12-31 07:00:34

Tags for this article:

Health
Articles
Pharmacy
AstraZeneca
Södertälje Municipality
Sanofi
Osimertinib
Adherence

Click the tags to see associated articles and topics

View Article Details
J&J's Rybrevant in Combo with Lazertinib Clears Phase III in NSCLC - BioSpace

Added to Collection on: 2023-09-28 20:03:05

Tags for this article:

Lung cancer
Breakthrough therapy
Tyrosine kinase inhibitors
Ethers
T790M
Non-small-cell lung cancer
Epidermal growth factor receptor
Amivantamab
Bispecific monoclonal antibody
Protein kinase inhibitor
Osimertinib
Draft:Lazertinib
Johnson & Johnson

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Tagrisso-Chemo Combo Under FDA Priority Review For Most Common Form ...

Added to Collection on: 2023-10-16 20:23:03

Tags for this article:

Lung cancer
Progression-free survival
Non-small-cell lung cancer
Osimertinib
Small-cell carcinoma
Survival rate
Draft:Lazertinib
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's cancer drug gets priority review from US FDA - MarketScreener

Added to Collection on: 2023-10-16 13:37:52

Tags for this article:

Lung cancer
Breakthrough therapy
Orphan drugs
Ethers
Antineoplastic drugs
Osimertinib
Small-cell carcinoma
Non-small-cell lung cancer
Brain metastasis
Priority review
Epidermal growth factor receptor
Food and Drug Administration
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Tagrisso gets FDA priority review in lung cancer subtype | Seeking Alpha

Added to Collection on: 2023-10-16 12:30:50

Tags for this article:

Lung cancer
Breakthrough therapy
AstraZeneca
Osimertinib
Non-small-cell lung cancer
Oxford–AstraZeneca COVID-19 vaccine

Click the tags to see associated articles and topics

View Article Details